Drug intelligence / Profile preview

Turpentine Oil (Medismith Pharma Lab)

Development stage: Unknown
Lead developer: Medismith Pharma Lab
Modality: Small Molecules
Administration: Topical

Overview

Turpentine Oil is a natural product topical formulation manufactured by Medismith Pharma Lab, an Indian pharmaceutical company. Derived from pine tree resin, this volatile essential oil is traditionally utilized as a topical counterirritant and rubefacient. Its mechanism involves inducing local vasodilation and increasing blood flow to the site of application, which provides symptomatic relief from musculoskeletal conditions such as muscle and joint pain. The product is formulated according to British Pharmacopoeia (BP) standards and is intended exclusively for external use.

Brand names: Turpentine Oil BP
Other names: Turpentine oil

Targets

IL1R1 (Interleukin-1 Receptor Type 1)

Beyond the preview

Go deeper on Turpentine Oil (Medismith Pharma Lab).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Turpentine Oil (Medismith Pharma Lab).

Explore the full profile